A new era in the science and care of kidney diseases

C Zoccali, F Mallamaci, L Lightstone, V Jha… - Nature Reviews …, 2024 - nature.com
Notable progress in basic, translational and clinical nephrology research has been made
over the past five decades. Nonetheless, many challenges remain, including obstacles to …

[HTML][HTML] Nonpodocyte Roles of APOL1 Variants: An Evolving Paradigm

J Pell, S Nagata, MC Menon - Kidney360, 2023 - journals.lww.com
Since the seminal discovery of the trypanolytic, exonic variants in apolipoprotein L1 (APOL1)
and their association with kidney disease in individuals of recent African ancestry, a wide …

Phenotypes of APOL1 high-risk status subjects

JB Kopp, T Yoshida - Journal of the American Society of …, 2023 - journals.lww.com
In this issue of the JASN, Elliott and colleagues report the clinical characteristics of 239
patients harboring two apolipoprotein L1 (APOL1) kidney risk alleles, perhaps the largest …

[HTML][HTML] Focal Segmental Glomerulosclerosis Patient Baseline Characteristics in the Sparsentan Phase 3 DUPLEX Study

H Trachtman, J Radhakrishnan, MN Rheault… - Kidney International …, 2024 - Elsevier
Introduction The phase 3 DUPLEX trial is evaluating sparsentan, a novel,
nonimmunosuppressive, single-molecule dual endothelin angiotensin receptor antagonist …

Integrating Genetic Ancestry into Clinical Care: Accuracy, Utility, and Stakeholder Views

JS Prettyman, TJ Hoffmann, S Biswas, A Rajkovic - medRxiv, 2024 - medrxiv.org
PURPOSE: This study aimed to evaluate the concordance of genetic ancestry reports from
different providers, assess the accuracy of genetic ancestry compared to self-identified race …

[HTML][HTML] Higher prevalence of kidney function impairment among older people living with HIV in Uganda

AJ Ssemasaazi, R Kalyesubula, YC Manabe… - Research …, 2024 - ncbi.nlm.nih.gov
Background People living with HIV (PLWH) are at risk of kidney function impairment due to
HIV-related inflammation, antiretroviral therapy (ART), diabetes mellitus, and hypertension …

Prevalence of Mendelian kidney disease among patients with high-risk APOL1 genotypes undergoing commercial genetic testing in the United States

RS Francisco Jr, S Punj, L Vincent, N Sanapareddy… - medRxiv, 2024 - medrxiv.org
Background: Among individuals with high-risk APOL1 genotypes, the lifetime risk of
developing kidney failure is~ 15%, indicating that other genetic variants or non-genetic …

[HTML][HTML] Prevalence of Mendelian kidney disease among patients with high-risk APOL1 genotypes undergoing commercial genetic testing in the United States

R da Silva Francisco Jr, S Punj, L Vincent… - Kidney International …, 2024 - Elsevier
Introduction Among individuals with high-risk APOL1 genotypes, the lifetime risk of
developing kidney failure is∼ 15%, indicating that other genetic variants or non-genetic …

[PDF][PDF] Who is eligible?

S Wilson - labcorpapol1test.com
APOL1 Genotyping Program Page 1 Patient is of African ancestry including those who self-identify
as Black, African American, African or Afro-Caribbean. Patient has a diagnosis of non-diabetic …